Plain-English translation of NCT05039684 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether tafluprost, a preservative-free eye drop medication, causes fewer problems on the eye's surface compared to two versions of latanoprost (one with preservative, one without). Researchers want to understand how these common glaucoma medications affect the eye's surface over time and what signs of inflammation develop with long-term use.
Eye drop medications used to treat glaucoma and high eye pressure are very effective at lowering pressure in the eye, but the preservatives in some formulations can irritate the eye's surface and cause inflammation, redness, and discomfort over months or years. This trial aims to compare which medication option causes the least damage to the eye's surface.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic for eye exams and tests that check the health and inflammation of your eye's surface. Depending on which group you are assigned to, you may continue taking your current eye drop medication, switch to a different one being studied, or remain untreated if you are in the control group. The study will collect small samples from your eye's surface to measure inflammation markers and assess any changes over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Spain